In silico multicellular systems biology and minimal genomes

Drug Discovery Today

Volumn 8, Issue 24, 2003, Pages 1121-1127

  Werner, Eric ^a  

^a Cellnomica   (United States)

Author keywords

Drug DiscoveryBioinformatics; Genome; Genome semantics; Minimal cell; Minimal genome; Minimal multicellular organisms; Multicellular pharmacodynamics; Regulatory networks; Systems biology hierarchy; Techniques Methods

Indexed keywords

ANIMAL; BIOENGINEERING; BIOLOGICAL MODEL; BIOLOGY; CARCINOMA; CELL ACTIVITY; CELL STRUCTURE; CHIMPANZEE; COMPUTER MODEL; COMPUTER SIMULATION; CYTOLOGY; DRUG DESIGN; GENE CONSTRUCT; GENETICS; GENOME; HUMAN; IN VIVO STUDY; NEOPLASM; NONHUMAN; PHARMACOKINETICS; REVIEW; SEMANTICS;

ANIMALS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; GENOME; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PHARMACOKINETICS;

EID: 0348109458     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02918-0     Document Type: Review

References (47)

1. Frishman D., et al. Comprehensive, comprehensible, distributed and intelligent databases: current status. Bioinformatics. 14:1998;551-561.
2. Frishman D., et al. Online genomics facilities in the new millennium. Pharmacogenomics. 3:2002;265-271.
3. Bolouri H., Davidson E.H. Modeling transcriptional regulatory networks. Bioessays. 24:2002;1118-1129.
4. Brown C.T., et al. New computational approaches for analysis of cis-regulatory networks. Dev. Biol. 246:2002;86-102.
5. Davidson E.H. Genomic Regulatory Systems: Development and Evolution. 2001;Academic Press.
6. Werner, E. (1996) Logical foundations of distributed artificial intelligence. In Foundations of Distributed Artificial Intelligence, (O'Hare, G. and Jennings, N., eds), Wiley.
7. Werner, E. (1992) The design of multi-agent systems. In Decentralized AI (Vol 3) (Werner, E. and Demazeau, Y., eds), Elsevier Science Publishers B.V.
8. Kitano H. Systems biology: a brief overview. Science. 295:2002;1662-1664.
9. Kitano H. Computational systems biology. Nature. 420:2002;206-210.
10. Werner, E. (2003) In silico cell signaling underground. Sci. STKE 170, PE8.
11. Carlson J.M., Doyle J. Complexity and robustness. Proc. Natl. Acad. Sci. U. S. A. 99:(Suppl 1):2002;2538-2545.
12. Csete M.E., Doyle J.C. Reverse engineering of biological complexity. Science. 295:2002;1664-1669.
13. Palsson B. The challenges of in silico biology. Nat. Biotechnol. 18:2000;1147-1150.
14. Palsson B.O. What lies beyond bioinformatics? Nat. Biotechnol. 15:1997;3-4.
15. Werner T. Cluster analysis and promoter modelling as bioinformatics tools for the identification of target genes from expression array data. Pharmacogenomics. 2:2001;25-36.
16. Werner T. Promoters can contribute to the elucidation of protein function. Trends Biotechnol. 21:2003;9-13.
17. van Someren E.P., et al. Genetic network modeling. Pharmacogenomics. 3:2002;507-525.
18. Bock J.R., Gough D.A. Whole-proteome interaction mining. Bioinformatics. 19:2003;125-134.
19. Godzik A. Fold recognition methods. Methods Biochem. Anal. 44:2003;525-546.
20. Bartlett G.J., et al. Inferring protein function from structure. Methods Biochem. Anal. 44:2003;387-407.
21. Smolen P., et al. Modeling transcriptional control in gene networks-methods, recent results, and future directions. Bull. Math. Biol. 62:2000;247-292.
22. Smolen P., et al. Mathematical modeling of gene networks. Neuron. 26:2000;567-580.
23. Neves S.R., Iyengar R. Modeling of signaling networks. Bioessays. 24:2002;1110-1117.
24. Edwards J.S., et al. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat. Biotechnol. 19:2001;125-130.
25. Werner, E. (1988) Toward a Theory of Communication and Cooperation for Multiagent Planning. Theoretical Aspects of Reasoning About Knowledge: Proceedings of the Second Conference, 129-143.
26. Tomita M. Whole-cell simulation: a grand challenge of the 21st century. Trends Biotechnol. 19:2001;205-210.
27. Tomita M., et al. E-CELL: software environment for whole-cell simulation. Bioinformatics. 15:1999;72-84.
28. Loew L.M., Schaff J.C. The Virtual Cell: a software environment for computational cell biology. Trends Biotechnol. 19:2001;401-406.
29. Noble D. Modelling the heart: insights, failures and progress. Bioessays. 24:2002;1155-1163.
30. Lewis E.B. A gene complex controlling segmentation in Drosophila. Nature. 276:1978;565-570.
31. Lewis E.B. The bithorax complex: the first fifty years. Int. J. Dev. Biol. 42:1998;403-415.
32. Nusslein-Volhard C., Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature. 287:1980;795-801.
33. St Johnston D., Nusslein-Volhard C. The origin of pattern and polarity in the Drosophila embryo. Cell. 68:1992;201-219.
34. Venter C. Charting the biologic frontier. Interview by Val J. Halamandaris. Caring. 22:2003;32-40.
35. Venter, C. (2003) Talk on minimal cell and Q&A. World Drug Discovery and Development Summit, 17-19 February 2003, Copenhagen, Denmark.
36. Schilling C.H., et al. Genome-scale metabolic model of Helicobacter pylori 26695. J. Bacteriol. 184:2002;4582-4593.
37. Kolisnychenko V., et al. Engineering a reduced Escherichia coli genome. Genome Res. 12:2002;640-647.
38. Kobayashi K., et al. Essential Bacillus subtilis genes. Proc. Natl. Acad. Sci. U. S. A. 100:2003;4678-4683.
39. Fraser C.M., et al. The minimal gene complement of Mycoplasma genitalium. Science. 270:1995;397-403.
40. Hutchison C.A., et al. Global transposon mutagenesis and a minimal Mycoplasma genome. Science. 286:1999;2165-2169.
41. Carlson J.M., Doyle J. Highly optimized tolerance: robustness and design in complex systems. Phys. Rev. Lett. 84:2000;2529-2532.
42. Eldar A., et al. Robustness of the BMP morphogen gradient in Drosophila embryonic patterning. Nature. 419:2002;304-308.
43. Wilke C.O., Adami C. Evolution of mutational robustness. Mutat. Res. 522:2003;3-11.
44. Jackson, R.C. Predictive software for drug design and development. Pharm. Dev. Reg. 1, 159-168.
45. Lipinski C.A. Chris Lipinski discusses life and chemistry after the Rule of Five. Drug Discov. Today. 8:2003;12-16.
46. Lipinski C.A., et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:2001;3-26.
47. Crick F. Central dogma of molecular biology. Nature. 227:1970;561-563.